We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-8.74%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.03B
AUM Growth
-$97.2M
Cap. Flow
+$5.15M
Cap. Flow %
0.5%
Top 10 Hldgs %
54.98%
Holding
5,775
New
1,132
Increased
1,485
Reduced
1,487
Closed
1,545

Sector Composition

Rank Sector Weight
1 Financials 2.17%
2 Healthcare 1.69%
3 Industrials 1.67%
4 Technology 1.59%
5 Consumer Discretionary 1.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSG icon
2301
Inseego
INSG
$90.5M
$10K ﹤0.01%
475
+435
+1,088% +$11.1K
INTG icon
2302
InterGroup Corp
INTG
$67.4M
$10K ﹤0.01%
372
-124
-25% -$3.25K
IOR
2303
Income Opportunity Realty Investors
IOR
$10K ﹤0.01%
1,312
-144
-10% -$1.17K
IPOS icon
2304
Renaissance International IPO ETF
IPOS
$11.8M
$10K ﹤0.01%
535
-412
-44% -$8.54K
KBR icon
2305
KBR
KBR
$4.8B
$10K ﹤0.01%
+600
New +$10.6K
LAB icon
2306
Standard BioTools
LAB
$314M
$10K ﹤0.01%
1,237
+1,154
+1,390% +$18.2K
LSCC icon
2307
Lattice Semiconductor
LSCC
$18.5B
$10K ﹤0.01%
2,621
-1,756
-40% -$8.08K
MTH icon
2308
Meritage Homes
MTH
$4.86B
$10K ﹤0.01%
550
-1,250
-69% -$26.9K
ODC icon
2309
Oil-Dri
ODC
$1.34B
$10K ﹤0.01%
834
+634
+317% +$8.04K
PLBC icon
2310
Plumas Bancorp
PLBC
$429M
$10K ﹤0.01%
1,159
-212
-15% -$1.95K
RC
2311
Ready Capital
RC
$308M
$10K ﹤0.01%
+725
New +$11.1K
RMCF icon
2312
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$10K ﹤0.01%
879
+604
+220% +$7.48K
SF
2313
Stifel
SF
$12.6B
$10K ﹤0.01%
+531
New +$12K
SOXX icon
2314
iShares Semiconductor ETF
SOXX
$45.9B
$10K ﹤0.01%
384
-786
-67% -$22.3K
TXN icon
2315
Texas Instruments
TXN
$261B
$10K ﹤0.01%
+202
New +$9.86K
VBND icon
2316
Vident US Bond Strategy ETF
VBND
$526M
$10K ﹤0.01%
196
+157
+403% +$7.78K
VERU icon
2317
Veru
VERU
$37.4M
$10K ﹤0.01%
623
+474
+318% +$7.15K
VIA
2318
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$10K ﹤0.01%
+234
New +$9.39K
PLXP
2319
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$10K ﹤0.01%
+89
New +$10.2K
CDR
2320
DELISTED
Cedar Realty Trust, Inc
CDR
$10K ﹤0.01%
252
-1,298
-84% -$55.9K
HSTO
2321
DELISTED
Histogen Inc. Common Stock
HSTO
$10K ﹤0.01%
11
+10
+1,000% +$9.11K
ATRS
2322
DELISTED
Antares Pharma, Inc.
ATRS
$10K ﹤0.01%
5,707
-3,605
-39% -$7.07K
CONE
2323
DELISTED
CyrusOne Inc Common Stock
CONE
$10K ﹤0.01%
+300
New +$9.53K
JTD
2324
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
$10K ﹤0.01%
+737
New +$11K
QADB
2325
DELISTED
QAD Inc. Class B
QADB
$10K ﹤0.01%
470
-607
-56% -$12.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2015 Portfolio in Review

As of Q3 2015, Tower Research Capital (TRC) held 5,775 positions worth $1.03B, down 8.6% from $1.13B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Tower Research Capital (TRC)'s Q3 2015 filing shows 1,132 new, 1,485 increased, 1,487 reduced and 1,545 closed positions. Its largest new stake was iShares Russell 2000 ETF: 144,546 shares worth $15.8M. The largest sale was VanEck Semiconductor ETF, an estimated $34M.

By sector, the portfolio is most concentrated in Financials at 2.2% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2015 buy was iShares Russell 2000 ETF: 144,546 shares worth $15.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q3 2015, an estimated $37.1M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2015 reduction was VanEck Semiconductor ETF, cutting an estimated $34M.
  • Tower Research Capital (TRC) fully exited Vanguard Extended Market ETF in Q3 2015, selling an estimated $10M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 55% of its $1.03B portfolio in Q3 2015.
  • Tower Research Capital (TRC) opened 1,132 new positions and closed 1,545 in Q3 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 8.6% quarter-over-quarter to $1.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2015, filed 13 Nov 2015.